RBC Capital Downgrades OncoGenex Pharmaceuticals (OGXI) to Sector Perform
Tweet
Share
E-mailGet Alerts OGXI Hot Sheet
Price: $0.40 --0%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
RBC Capital downgraded OncoGenex Pharmaceuticals (NASDAQ: OGXI) from Outperform to Sector Perform with a price target of $4.50 (from $19.00).
For an analyst ratings summary and ratings history on OncoGenex Pharmaceuticals click here. For more ratings news on OncoGenex Pharmaceuticals click here.
Shares of OncoGenex Pharmaceuticals closed at $3.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Genuity Downgrades Antofagasta Plc. (ANTO:LN) (ANFGF) to Hold
- Essity AB (ESSITYB:SS) (ESSYY) PT Raised to SEK243 at Barclays
- JPMorgan Downgrades Boyd Gaming (BYD) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
